Elixinol Global Limited (Company) is expected to be admitted to the official list of ASX Limited (ASX) on Friday, 5 January 2018.
Official quotation of the Company’s shares is expected to commence at 11:00am AEDT on Monday, 8 January 2018. The Company has raised $20 million pursuant to the offer under a prospectus dated 28 November 2017 (Prospectus) by the issue of approximately 20 million shares at an issue price of $1.00 per share.
Quoted securities: |
25,005,409 ordinary shares fully paid |
ASX code: |
EXL |
Time: |
11:00am AEDT |
Date: |
8 January 2018 |
ASX Trade abbreviation: |
ELIXINOL |
ISIN: |
AU000000EXL4 |
Home branch: |
Sydney |
Industry classification: |
3030 - Household & Personal Products |
Registered office: |
Level 12, 680 George Street, Sydney NSW 2000 |
Company secretary: |
Mr Ron Dufficy |
Share registry: |
Computershare Investor Services Pty Limited Level 4, 60 Carrington Street, Sydney NSW 2000 |
Balance date: |
31 December |
CHESS: |
Participating. The Company will also operate an issuer sponsored-subregister |
Place of incorporation: |
New South Wales, Australia |
Dividend policy: |
N/A |
Activities: |
Manufacture and distribution of industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products |
Restricted securities: |
77,870,572 ordinary shares fully paid restricted for 24 months from the date of commencement of official quotation 52,559 ordinary shares fully paid restricted for 12 months from 27 December 2017 |
Unquoted securities: |
None |
For further details, please refer to the Company’s prospectus dated 28 November 2017.
Please contact the Elixinol Global IPO Information Line on 1300 140 587 (within Australia) and +613 9415 4108 (outside Australia) from 8.30am to 5.00pm (Sydney time), Monday to Friday (excluding public holidays).
Johanna O’Shea, Adviser, Listings Compliance
Johanna O’Shea
+61 (02) 9227 0000
info@asx.com.au